We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 3.85% | 0.135 | 0.13 | 0.14 | 0.135 | 0.13 | 0.13 | 130,555 | 09:18:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2018 13:15 | Adjective department or adjectives' department, but not adjectives departmentI think | mrc2u | |
31/7/2018 10:52 | I take it some posting here never sold at the chart high pointy bits I understand your angst however a girl at school told me once '' using bad language and/or swear words showed a lack of command of the English vocabulary , especially in the adjectives department '' She was 13 yrs old at the time, but I was very impressed non the less | buywell3 | |
30/7/2018 23:37 | Not the same, but the genesis was written large.. | maxk | |
30/7/2018 13:28 | Buywell old boyCan't you read the announcement that gives you the answer to who the seller is?Go on, give it a go. It will stop you wasting your time tooLet me know if you need any more cluesMrC | mrc2u | |
30/7/2018 11:14 | other views might be Who is the seller ? or Who are the sellers ? How deep are the BoD's pockets to keep soaking up the share sales ? | buywell3 | |
30/7/2018 10:17 | "purchased" 2,234,222 ordinary shares | maxk | |
30/7/2018 10:01 | Nice to see another director stepping up to the plate....... | chrisdgb | |
30/7/2018 09:52 | buywell3 (9451): I note the DEMG Chart hook is now in "Chart hook" ? What piece of charting lore is this? | arf dysg | |
30/7/2018 09:50 | mrC2u, you might have a point. Maaaaaaaaaybe. | arf dysg | |
28/7/2018 10:59 | I note the DEMG Chart hook is now in (See top RHS chart on thread header) Re recent keen buys at sub a penny , I wonder who has been selling ? And how big was the queue of buyers ? | buywell3 | |
27/7/2018 17:52 | Only one o in no though | mrc2u | |
27/7/2018 15:43 | No, no, no, no, no, no, noooooooooooo ooooooooo oooooooooo ooooooooooooooo ooooooooooo oooooooooooooooooooo | arf dysg | |
27/7/2018 15:36 | Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), was informed yesterday that Nigel Keen, Chairman of the Company, purchased 6,000,000 ordinary shares of 1 pence each in the Company... No! No, no, no, no, no, no, nooooooooooooooooooo The word "pence" is plural!! Look at the writing on one of those small coins you have ... it's ONE PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY !!!!!!!!!!!!!!!!!!!! It should be "ordinary shares of ONE PENNY" !!!!!!!!! I think I need to lie down in a dark room. | arf dysg | |
27/7/2018 11:16 | Averaging down as trading deteriorates and the share price chart of a company falls like a brick ie '' catching a falling knife'' is not considered a clever strategy by most clued up investors. 26 FEB 2016 Nigel John Keen NON-EXECUTIVE DIRECTOR,CHAIRMAN 12,500,000 0.04 500.00 k Purchase 10 JUN 2014 Nigel John Keen NON-EXECUTIVE DIRECTOR,CHAIRMAN 1,363,636 0.11 150.00 k Purchase 23 JAN 2013 Nigel John Keen NON-EXECUTIVE DIRECTOR,CHAIRMAN 789,000 0.19 149.91 k Purchase 30 OCT 2009 Nigel John Keen NON-EXECUTIVE DIRECTOR,CHAIRMAN 1,066,666 0.09 96.00 k Purchase 27 OCT 2005 Nigel John Keen NON-EXECUTIVE DIRECTOR,CHAIRMAN 263,158 0.19 50.66 k fair play to him , he keeps on doing it The Bottom Line Averaging down is a viable investment strategy for stocks, mutual funds and exchange-traded funds. However, due care must be exercised in deciding which positions to average down. The strategy is best restricted to blue chips that satisfy stringent selection criteria such as a long-term track record, minimal debt and solid cash flows. I thus draw the obvious conclusion | buywell3 | |
27/7/2018 11:07 | Well, fair play to a £50,000 share purchase........ | chrisdgb | |
26/7/2018 14:07 | IMO DEMG is now in the A&E on life support The question is how long before the equipment rendering same be left switched on ? | buywell3 | |
26/7/2018 11:05 | catch007 The problem is that until you run something like this for a lot of years, nobody will be able to predict whether it will be viable or not, as its subject to years of gaining approvals, tests etc. etc. Then you have to wait to find out whether all that effort actually gives you repeat sales or not. My main objection to the board is not that they've run it wrongly, which is an easy criticism given the situation (so who would run it better and why, because you can't force the market imo), but that they've not been clear with investors about the reasons for lack of growth in the US. Which is even now making it difficult to make any judgement, even for a new investor who fancies a dabble. Specifically, DEMG had a good chunk of revenue ages ago from the very first US hospitals, which has not significantly increased with all the new additions. So the AGM question is: what on earth is different about all the additional hospitals, compared to the originals. Anyone can look back and see that initial US revenue and make the comparison. | yump | |
25/7/2018 15:25 | Hey! There are some ABSOLUTELY MASSIVE companies in the footsie with about a billion shares! | arf dysg | |
25/7/2018 14:08 | FWIW With the current share price now sub one penny and with many annual cash raising events behind it , going back years It is only the olde bull brigade with shares garnered at 30p or so , that never sold , that still believe and buy today. Another loss of $2M looks very likely Therefore the 1M cash left will need replacing in around 6 months With falling sales everywhere , and the share price approaching 0.8p , the next raise price would surely have to be 0.5p Which means to raise £2M ... to give this a chance to live another 12 months ie Another 400 Million shares sold , and with loan notes , the Billion shares mark gets hit | buywell3 | |
25/7/2018 13:49 | Generally its a mismanaged company with an inept over paid executive board trying to execute a continual groundhog day strategy that fails every time as the cost of sales creates recurring and increasing losses. The targeted market isn't buying in the volumes needed nor is there sufficient profit per unit for a sustainable business model. A case study on how not to run a business IMHO! | catch007 | |
25/7/2018 13:39 | Re the phrase '' together with changes in ordering by two large accounts, '' IMO I think this should have read ''together with losing two large accounts, '' time will tell to who dyor | buywell3 | |
25/7/2018 13:35 | Aortech about to go into orbit hxxps://www.share-ta | davisc7 | |
25/7/2018 13:29 | Well I'm sure some people partly bought in (me included) not because it looked like a road to riches, but because it seemed it might be a UK success story, as well as having a defendable niche and potential for good growth. For me, that was despite knowing that launching a medical device in general is a long drawn out and expensive process. Out of all the wonder-cures, medical stuff, it seemed that is was (just !!) a question of building up the users and then getting the holy-grail of repeat probe sales with little attached cost. Unfortunately it appears to be just like a commodity sale - you have to keep banging away at the sales process and not much of the purchasing is routine. I suppose it could just be that they've been unlucky recently with the changes in the US orders, but if ODM was firmly entrenched in the US hospital systems, there wouldn't be any changed orders. That part has never been fully explained. Perhaps a question to ask: What percentage of sales is dependent on DEMG OGM being routinely specified and what percentage is dependent on repeat sales effort. If DEMG don't know that statistic they really need a lot of heads to roll. Because the entire viability of the business depends on that. | yump | |
25/7/2018 12:46 | This would seem to be pretty much the end of the journey. So many years of dwindling hopes. The value of my investment is now paltry but I won't sell out as I've somehow become sentimentally attached to it (why do we do this?) | eclair |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions